Tight Timelines: The Biotech Existence

June 20, 2024

First Patient In 6 Weeks from Written Award

Learn how CRC partnered with an emerging biotech to overcome tight clinical timelines and successfully achieve the First Patient In milestone just 6 weeks from the written award. This case study showcases CRC’s rapid alignment, problem-solving capabilities, and operational excellence that not only met the sponsor’s stringent deadline but also boosted stakeholder confidence.

Download the full case study

< Older Post

Newer Post >
neural network

Speed Kills: Is Your Neuropsychiatric Trial at Risk?

September 10, 2025
Why do neuropsychiatric trials fail? Experts Dr. Steve Brannan and Dr. David Walling share strategies to protect investments in neuropsychiatric drug development.
Jason Casarella

CRC Appoints Jason Casarella, MBA as Chief Commercial Officer

September 2, 2025
Experienced CRO executive joins Cognitive Research Corporation to expand partnerships and strengthen its position as a leading CRO for CNS clinical trials
psychedelic mushrooms

The Renaissance of Psychedelic Research: History, Protocols, and Forward Trajectories

August 20, 2025
Psychedelic clinical research is advancing. Explore how trials with psilocybin, LSD, MDMA, and DMT are redefining protocols, standards, and future therapies.
Show More